This finding is in agreement with a previous study which showed that patients with ovarian and non-small cell lung cancer carrying SLFN11 hypermethylation in primary tumors had a poor response to both cisplatin and carboplatin treatments [45]. Here, SLFN11 is linked to non-small cell lung carcinoma.